Cynata Therapeutics Limited
CYYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$9,745 | -$14,277 | -$5,445 |
| Dep. & Amort. | $0 | $0 | $280 | $280 |
| Deferred Tax | $0 | $0 | -$327 | -$1,032 |
| Stock-Based Comp. | $0 | $0 | $327 | $1,032 |
| Change in WC | $86 | -$726 | -$684 | $1,007 |
| Other Non-Cash | -$8,807 | $511 | $399 | $860 |
| Operating Cash Flow | -$8,720 | -$9,961 | -$14,283 | -$3,298 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$50 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$50 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $8,137 | $0 | $6,724 | $0 |
| Stock Repurch. | -$522 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $210 |
| Financing Cash Flow | $7,615 | $0 | $6,724 | $210 |
| Forex Effect | -$0 | -$1 | -$72 | $170 |
| Net Chg. in Cash | -$1,156 | -$9,962 | -$7,631 | -$2,919 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,205 | $16,167 | $23,798 | $26,717 |
| End Cash | $5,050 | $6,205 | $16,167 | $23,798 |
| Free Cash Flow | -$8,770 | -$9,961 | -$14,283 | -$3,298 |